research and development

Showing 15 posts of 209 posts found.

Dr Geoffrey Nichol joins Ikaria

June 22, 2010
Research and Development Ikaria, appointment, research and development

US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …

MedImmune Ventures appoints Ron Laufer

June 18, 2010
Research and Development AstraZeneca, MedImmune, appointment, research and development

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …

ABPI appoints former AZ innovation head

June 17, 2010
Research and Development, Sales and Marketing ABPI, appointment, research and development, sales and marketing

UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …

Former FDA and MHRA regulators join Parexel Consulting

June 16, 2010
Research and Development CRO, Parexel, appointment, research and development

Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …

R&D: a new world order

June 16, 2010
Manufacturing and Production, Research and Development industry, job cuts, research, research and development

Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …

Novavax makes manufacturing promotions

June 16, 2010
Manufacturing and Production, Research and Development Novavax, appointment, manufacturing and production, research and development

US biotech company Novavax has made a brace of manufacturing management promotions. It has appointed John Madsen as head of …

Pfizer appoints neuroscience research head

June 10, 2010
Research and Development Pfizer, appointment, research and development

Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …

Dr Laurent Audoly joins Pieris

June 9, 2010
Research and Development Pieris, appointment, research and development

French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …

Idis appoints Richard Greatorex

June 8, 2010
Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …

UCB’s Kola joins Astex board

June 5, 2010
Research and Development Astex, UCB, appointment, research and development

Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …

Pfizer R&D head exits for AstraZeneca

May 27, 2010
Research and Development AstraZeneca, Pfizer, appointment, research and development

One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …

Silence Therapeutics promotes Jorg Kaufmann

May 21, 2010
Research and Development Silence Therapeutics, appointment, research and development, rnai

Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …

UCB’s Roch Doliveux joins Innovative Medicines Initiative board

May 19, 2010
Research and Development UCB, appointment, research and development

UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …

FerringSteveHowson

Steve Howson to lead Ferring UK

May 18, 2010
Research and Development, Sales and Marketing Ferring, appointment, research and development, sales and marketing

Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …

Cedra appoints Anthony Busa

May 14, 2010
Research and Development CRO, Cedra, appointment, research and development

Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting …

The Gateway to Local Adoption Series

Latest content